Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
暂无分享，去创建一个
P. Parizel | F. Prósper | W. van Hecke | N. Hens | P. Cras | H. Wiendl | C. Gross | A. ten Brinke | A. Ribbens | Z. Berneman | G. Nijs | T. Billiet | E. Martínez-Cáceres | M. V. van Ham | A. Barriocanal | N. Cools | S. Presas-Rodríguez | I. Wens | A. Kip | C. Ramo-Tello | B. Willekens | H. Verheij | B. Quirant-Sánchez | S. Inogés | M. Couttenye | Wai-Ping Lee | J. Navarro-Barriuso | Maxime De Laere | A. Massuet-Vilamajó | J. Derdelinckx | A. Lopez-Diaz de Cerio | A. Teniente‐Serra | MJ Mansilla | Geert Adams | A. M. Barriocanal | A. López-Díaz de Cerio